Junliang Cai
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 1
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 8
-
- Cancer Genomics and Diagnostics 1
-
- Radiomics and Machine Learning in Medical Imaging 2
-
- Colorectal and Anal Carcinomas 2
- Head and Neck Surgical Oncology 1
- Co-authors
- Shun LüJifeng FengYuankai ShiYing ChengJianying ZhouAlexander LuftChristine BaudeletLi Zhang
- Partner nations
- United StatesChinaJapan
In The Last Decade
Junliang Cai
12 papers receiving 524 citations
Hit Papers
Peers
Comparison fields: 5 of 42
- Oncology 451
- Pulmonary and Respiratory Medicine 397
- Cancer Research 52
- Otorhinolaryngology 15
- Immunology 65
Countries citing papers authored by Junliang Cai
This map shows the geographic impact of Junliang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junliang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junliang Cai more than expected).
Fields of papers citing papers by Junliang Cai
This network shows the impact of papers produced by Junliang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junliang Cai. The network helps show where Junliang Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junliang Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 15 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 90 | |
| 8 | 2021 | 65 | |
| 9 | 2019 | 17 | |
| 10 | Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trialbreakdown → | 2019 | 265 |
| 11 | 2018 | 1 | |
| 12 | 2014 | 21 |
About Junliang Cai
Junliang Cai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 12 papers that have together received 534 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Colorectal and Anal Carcinomas (2 papers), Head and Neck Surgical Oncology (1 paper), Cancer Genomics and Diagnostics (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (451 citations), Pulmonary and Respiratory Medicine (397 citations) and Cancer Research (52 citations). Junliang Cai has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Shun Lü, Jifeng Feng, Yuankai Shi, Ying Cheng, Jianying Zhou, Alexander Luft, Christine Baudelet, Li Zhang, Tony Mok and Caicun Zhou. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.